Beginning Next Week: InsideCounsel will become part of Corporate Counsel. Bringing these two industry-leading websites together will now give you comprehensive coverage of the full spectrum of issues affecting today's General Counsel at companies of all sizes. You will continue to receive expert analysis on key issues including corporate litigation, labor developments, tech initiatives and intellectual property, as well as Women, Influence & Power in Law (WIPL) professional development content. Plus we'll be serving all ALM legal publications from one interconnected platform, powered by, giving you easy access to additional relevant content from other InsideCounsel sister publications.

To prevent a disruption in service, you will be automatically redirected to the new site next week. Thank you for being a valued InsideCounsel reader!


Bankrupt pharmacy linked to meningitis outbreak wants to redeem insurance policies to pay creditors

Many states want the pharmacy’s license revoked, which would keep it from redeeming the policies

The bankruptcy estate of the pharmacy that allegedly caused a deadly meningitis outbreak in the U.S. last year wants to be able to redeem its insurance policies, worth several million dollars, to pay off debts to its creditors.

The New England Compounding Center (NECC) filed for Chapter 11 bankruptcy in December 2012, after fungal meningitis-tainted steroids that it manufactured were linked to an outbreak that killed 53 people and infected hundreds more. Some of the NECC’s creditors are victims of the outbreak.

The total claims of all the creditors exceed NECC’s assets, which are listed as between $1 million and $10 million. Paul Moore, the trustee for NECC’s estate, wants to be able to redeem the insurance policies as a way of putting a dent in the claims. However, at least 28 states want NECC’s license to be suspended, forfeited or revoked, due to the outbreak, which would prevent the estate from redeeming the policies. Moore is requesting court approval to hire Boston law firm Collora to battle the states on this issue.

Read more at Thomson Reuters.


Follow the NECC’s saga on InsideCounsel:

FDA proposes charging compounding pharmacies fees to fund extra oversight in wake of meningitis outbreak

Pharmacy linked to meningitis outbreak paid owners $16 million in 2012

Manufacturer of allegedly contaminated steroid tries to distance itself from meningitis outbreak

Chief pharmacist of contaminated steroid manufacturer subpoenaed for meningitis hearing

Lawsuits against pharmacy that allegedly caused meningitis outbreak on the rise in Michigan

Join the Conversation

Advertisement. Closing in 15 seconds.